This post is part of Bill of Health‘s symposium on the Law, Ethics, and Science of Re-Identification Demonstrations. You can call up all of the symposium contributions here. Please note that Bill of Health continues to have problems receiving some comments. If you post a comment to any symposium piece and do not see it…
This post is part of Bill of Health‘s symposium on the Law, Ethics, and Science of Re-Identification Demonstrations. You can call up all of the symposium contributions here. Please note that Bill of Health continues to have problems receiving some comments. If you post a comment to any symposium piece and do not see it…
By Michelle Meyer This is the second post in Bill of Health‘s symposium on the Law, Ethics, and Science of Re-Identification Demonstrations. We’ll have more contributions throughout the week, and extending at least into early next week. Background on the symposium is here. You can call up all of the symposium contributions by clicking here…
By Michelle Meyer This is the first post in Bill of Health‘s symposium on the Law, Ethics, and Science of Re-Identification Demonstrations. We’ll have more contributions throughout the week. Background on the symposium is here. You can call up all of the symposium contributions by clicking here (or by clicking on the “Re-Identification Symposium” category…
By Leslie Francis [this is a cross post from HealthLawProf] Warning: some of this post is HIPAA-wonky. But read on: the punch line is that HIPAA does not protect the living or the dead from blanket release of medical records to their personal representatives—unless state law provides otherwise or patients have thought to specify in…
By The Petrie-Flom Center
By Michelle Meyer Over the course of the last fifteen or so years, the belief that “de-identification” of personally identifiable information preserves the anonymity of those individuals has been repeatedly called up short by scholars and journalists. It would be difficult to overstate the importance, for privacy law and policy, of the early work of…
By The Petrie-Flom Center
By Dov Fox Yesterday, I wrote about Ryan Abbott‘s new article that proposes to use health information exchanges to improve the collection of data about the safety of approved drugs. Today, I want to address his recommendation that the government pay private parties to help the Food and Drug Administration conduct post-market drug surveillance. The article argues that health information…
By Dov Fox So much new data are created every day that 90 percent of all data worldwide has emerged in just the last two years. This information revolution has the potential, argues Bill of Health guest blogger Ryan Abbott, to transform how we develop new drugs, set clinical practices, and finance health care. His interesting new article paints an alluring “vision…
